Document is current
Any future updates will be listed below
-
Authors
Nakaya, Yosuke https://orcid.org/0000-0003-3337-1599
Nakamae, Hirohisa https://orcid.org/0000-0003-4203-990X
Harada, Naonori
Okamura, Hiroshi
Sakatoku, Kazuki
Ido, Kentaro
Makuuchi, Yosuke
Kuno, Masatomo https://orcid.org/0000-0003-4548-147X
Takakuwa, Teruhito
Hirose, Asao
Nakamae, Mika https://orcid.org/0000-0002-9200-4804
Nishimoto, Mitsutaka
Nakashima, Yasuhiro https://orcid.org/0000-0003-3025-723X
Koh, Hideo
Hino, Masayuki
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (20K07788)
- License Information
-
More Information
Article History
Received: 14 January 2023
Revised: 6 April 2023
Accepted: 11 April 2023
First Online: 28 April 2023
Competing interests
: HN received research funding from Takeda Pharmaceutical Co., Ltd., and honoraria from Nippon Shinyaku Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Astellas Pharma Inc., and Takeda Pharmaceutical Co., Ltd. HO received research funding from Takeda Pharmaceutical Co., Ltd., and honoraria from Nippon Shinyaku Co., Ltd. TT received research funding from Pfizer Japan Inc., and honoraria from Sanofi K.K., Chugai Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., and Takeda Pharmaceutical Co., Ltd. MN (Nishimoto) received research funding from Pfizer Japan Inc., Takeda Pharmaceutical Co., Ltd., and honoraria from Nippon Shinyaku Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., and Takeda Pharmaceutical Co., Ltd. YN (Nakashima) received research funding from Chugai Pharmaceutical Co., Ltd., Astellas Pharma Inc., and honoraria from Chugai Pharmaceutical Co., Ltd. and Kyowa Kirin Co., Ltd. HK received research funding from Takeda Pharmaceutical Co., Ltd., and honoraria from Takeda Pharmaceutical Co., Ltd. MH received research funding from Nippon Shinyaku Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., Astellas Pharma Inc., Takeda Pharmaceutical Co., Ltd., and honoraria from Sanofi K.K., Nippon Shinyaku Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., Pfizer Japan Inc., Astellas Pharma Inc., and Takeda Pharmaceutical Co., Ltd.
